The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Telemedicine-supervised cancer therapy for patients with an aggressive lymphoma and metastatic lung cancer in the U.S. Veterans Affairs National TeleOncology Service.
 
Chenyu Lin
No Relationships to Disclose
 
Katherine I. Zhou
No Relationships to Disclose
 
Zachary R. Burningham
Research Funding - Abbvie; Genentech/Roche; Pharmacyclics
 
Kerry G. Rowe
No Relationships to Disclose
 
Tori Anglin-Foote
No Relationships to Disclose
 
Mark Maddox
No Relationships to Disclose
 
Daphne Ruth Friedman
Stock and Other Ownership Interests - BIOGEN (I); CVS (I); JOHNSON & JOHNSON (JNJ) (I); United Health Group (I); Zoetis (I)
Research Funding - Loxo/Lilly (Inst); Oncopeptides (Inst); TG Therapeutics (Inst)
 
Ahmad Sami Halwani
Research Funding - Abbvie (Inst); Abbvie/Genentech (Inst); Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Immune Design (Inst); Kyowa Hakko Kirin (Inst); miRagen (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Immune Design; Pharmacyclics; Seagen
 
Vida Almario Passero
No Relationships to Disclose
 
Michael J. Kelley
Research Funding - Bristol-Myers Squibb (Inst); EQRx; Genentech (Inst); Mirati Therapeutics; Novartis (Inst); Regeneron (Inst)
 
Thomas David Rodgers
No Relationships to Disclose